Replies to post #22634 on Arena Pharmaceuticals, Inc. (ARNA)

[operating_line]

I agree with you. ARNA was held back at the equivalent of USD135 per share immediately after the FDA decision on Belviq. That must have been an enormous undertaking given the momentum for the first obesity drug ever approved. The changes in price and relentless drop over years wore most retail out. The change in attitude in the media is clear with blame placed on past management this month.

The Bloomberg article on $ARNA illustrated nicely just how incredibly overvalued that stock is today.

— Adam Feuerstein ✡️ (@adamfeuerstein) July 9, 2012

$ARNA pipeline is legit. You’re remembering the past correctly, but different company today.

— Adam Feuerstein ✡️ (@adamfeuerstein) November 15, 2018

At the same time, the stock has been carefully labelled "speculative". That is like waving a red flag to a bull. The bull will come soon enough.

https://seekingalpha.com/article/4222767-arena-pharmaceuticals-speculative-cramers-lightning-round-11-15-18

Short % has been dropping over the month
https://fintel.io/ss/us/arna